Home LiteratureArticle Details
PMID: 1095912 Published · ppublish English Journal Article Review

Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Molecular and cellular biochemistry ·Vol. 7 ·No. 2 ·1975-05-30 ·Pages 87-104

Lederer E, Adam A, Ciorbaru R, Petit JF, Wietzerbin J

Abstract

暂无摘要

MeSH Terms
Adjuvants, Immunologic Antineoplastic Agents Cell Wall/analysis,immunology Disaccharides/analysis Freund's Adjuvant Glycolipids/analysis Glycopeptides/analysis Macromolecular Substances Methanol Mitogens Muramic Acids/analysis Mycobacterium/analysis,immunology Mycolic Acids/analysis Oligopeptides/analysis Peptidoglycan/analysis Solubility Species Specificity Subcellular Fractions/analysis
Chemicals
Adjuvants, Immunologic Antineoplastic Agents Disaccharides Glycolipids Glycopeptides Macromolecular Substances Mitogens Muramic Acids Mycolic Acids Oligopeptides Peptidoglycan Freund's Adjuvant Methanol
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Lederer E
Adam A
Ciorbaru R
Petit J F
Wietzerbin J
References (165)
165 references, click to expand
  1. [Chemical and biological properties of phosphatide fractions isolated from "the methylic antigen" of Mycobacterium tuberculosis].
    Bull Soc Chim Biol (Paris). 1965;47(11):2039-46 PMID: 4956688
  2. The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells.
    J Gen Microbiol. 1973 Jul;77(1):79-87 PMID: 4579442
  3. Immunopotentiation with BCG. I. Immune response to different strains and preparations.
    J Natl Cancer Inst. 1973 Nov;51(5):1655-67 PMID: 4587140
  4. Enhancement of cord factor-toxicity by sulfolipid.
    Jpn J Med Sci Biol. 1974 Apr;27(2):120-4 PMID: 4209930
  5. Chemical analysis of a mycolic acid-arabinogalactan-mucopeptide complex of mycobacterial cell wall.
    Biochim Biophys Acta. 1970 Jun;208(3):434-43 PMID: 4248372
  6. Chemical characteristics and classification of nocardiae.
    Can J Microbiol. 1973 Aug;19(8):965-72 PMID: 4752341
  7. Effect of anti-cord factor antibody on experimental tuberculosis in mice.
    Infect Immun. 1973 Jan;7(1):14-21 PMID: 4632133
  8. Contribution to the study of the structure of adjuvant active waxes D from mycobacteria: Isolation of a peptidoglycan.
    FEBS Lett. 1968 Nov;2(1):7-9 PMID: 11946253
  9. The amino acids of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Presence of a poly(L-glutamic acid).
    Eur J Biochem. 1973 Feb 1;32(3):525-32 PMID: 4632511
  10. Structural studies on the myo-inositol phospholipids of Mycobacterium tuberculosis (var. bovis, strain BCG).
    J Biol Chem. 1963 Jan;238:69-76 PMID: 13966180
  11. The occurence of methyl ethers of rhamose and fucose in specific glycolipids of certain mycobacteria.
    Biochem J. 1961 Aug;80:309-18 PMID: 13764963
  12. Nature of the receptor substance of Mycobacterium smegmatis for D4 bacteriophage adsorption.
    J Bacteriol. 1972 Aug;111(2):404-11 PMID: 5053464
  13. Immunotherapy of malignant melanoma. A clinical trial.
    Cancer. 1973 Jul;32(1):97-103 PMID: 4123794
  14. FEBS Lett. 1970 Mar 16;7(1):64-67 PMID: 11947432
  15. [Cell wall of a virulent human strain of Mycobacterium tuberculosis. 1. Preparation and chemical analysis].
    Bull Soc Chim Biol (Paris). 1969 Jul 25;51(3):613-20 PMID: 4311277
  16. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
    Jpn J Med Sci Biol. 1973 Apr;26(2):71-85 PMID: 4585343
  17. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Cancer Res. 1974 Jul;34(7):1668-70 PMID: 4599359
  18. Studies on the firmly bound lipids of human tubercle bacillus. I. Isolation of arabinose mycolate.
    J Biochem. 1962 Sep;52:200-6 PMID: 13965782
  19. Nonspecific stimulation of tumor-associated immunity by methanol-soluble fraction of Mycobacterium butyricum.
    Cancer Res. 1972 Apr;32(4):795-803 PMID: 4501928
  20. [Mass spectometry of glycolipids. I. Structure of the "cord factor" of Corynebacterium diphtheriae].
    Eur J Biochem. 1967 May;1(3):353-6 PMID: 4964746
  21. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
    J Natl Cancer Inst. 1973 Jul;51(1):45-56 PMID: 4352753
  22. Muramic acid phosphate as a component of the mucopeptide of Gram-positive bacteria.
    J Biol Chem. 1967 Feb 10;242(3):471-6 PMID: 4290217
  23. Studies on peptides, glycopeptides and antigenic polysaccharide-glycopeptide complexes isolated from an L-11 enzyme lysate of the cell walls of Mycobacterium tuberculosis strain H37Rv.
    Biken J. 1970 Dec;13(4):249-75 PMID: 4994913
  24. FURTHER IMMUNOLOGIC STUDIES OF ADJUVANT DISEASE IN THE RAT.
    Int Arch Allergy Appl Immunol. 1963;23:331-47 PMID: 14083108
  25. [On the structure and biogenesis of the alpha-avimycolic acids of Mycobacterium avium].
    C R Acad Sci Hebd Seances Acad Sci D. 1965 Oct 4;261(14):2771-4 PMID: 4954696
  26. [Adjuvant activity of peptidoglyoans from mycobacteria].
    C R Acad Sci Hebd Seances Acad Sci D. 1974 Feb 4;278(6):799-801 PMID: 4211289
  27. Structure and immunological properties of D-arabino-D-galactans isolated from cell walls of Mycobacterium species.
    J Biochem. 1974 Jul;76(1):15-27 PMID: 4215801
  28. Structural investigations on cell walls of Nocardia sp. The wall lipid and peptidoglycan moieties of Nocardia kirovani.
    Eur J Biochem. 1972 Aug 18;29(1):156-66 PMID: 5083099
  29. [Structure of the aglycones of mycosides A and B].
    Tetrahedron Lett. 1965 Sep;(35):3135-43 PMID: 5318336
  30. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    J Natl Cancer Inst. 1974 Jan;52(1):103-11 PMID: 4359409
  31. In vitro evidence of specific BCG-induced immunity to malignant melanoma in BALB-c mice.
    J Natl Cancer Inst. 1974 Jun;52(6):1913-5 PMID: 4834418
  32. Effect of BCG infection on leukemia and polyoma in mice and hamsters.
    Proc Soc Exp Biol Med. 1962 Dec;111:739-42 PMID: 13929573
  33. FEBS Lett. 1969 Jul;4(2):87-92 PMID: 11947153
  34. Chemical analyses of mycobacterial cell walls.
    Biochim Biophys Acta. 1968 Apr 16;158(1):130-43 PMID: 4968065
  35. Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli.
    Natl Cancer Inst Monogr. 1972 Dec;35:157-71 PMID: 4633406
  36. Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.
    Infect Immun. 1973 Jun;7(6):855-61 PMID: 4716544
  37. Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report.
    J Natl Cancer Inst. 1974 Jan;52(1):19-24 PMID: 4590009
  38. BCG vaccination and acute leukaemia.
    Biomedicine. 1974 Mar 20;21(3):132-4 PMID: 4529629
  39. [Adjuvant activity of Gram-negative bacterial peptidoglycans in delayed hypersensitivity].
    C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 25;276(26):3499-500 PMID: 4199082
  40. Studies on cell walls of Mycobacteria. II. Constitution of polysaccharides from BCG cell walls.
    J Biochem. 1966 May;59(5):511-20 PMID: 4289814
  41. Immunotherapy of human melanomas and sarcomas.
    Natl Cancer Inst Monogr. 1972 Dec;35:375-8 PMID: 4659050
  42. Immunotherapy of patients with cancer.
    Surgery. 1973 Jul;74(1):59-68 PMID: 4715883
  43. [Isolation of arabinose phosphate from the walls of Mycobacterium tuberculosis H 37 Ra].
    C R Acad Sci Hebd Seances Acad Sci D. 1973 Nov 5;277(18):1949-51 PMID: 4210617
  44. The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement of macrophages.
    J Immunol. 1974 Jul;113(1):395-403 PMID: 4134068
  45. BCG and cancer (first of two parts).
    N Engl J Med. 1974 Jun 20;290(25):1413-20 PMID: 4364286
  46. Hydrosoluble adjuvant-active mycobacterial fractions of low molecular weight.
    FEBS Lett. 1973 Sep 15;35(2):317-21 PMID: 4200685
  47. Corynebacterium diphtheriae and its relatives.
    Bacteriol Rev. 1970 Dec;34(4):378-422 PMID: 4322195
  48. Mycosides: a new class of type-specific glycolipids of Mycobacteria.
    Nature. 1960 Jun 11;186:887-8 PMID: 13831939
  49. Biosynthesis of mycolic acids. Formation of a C32 beta-keto ester from palmitic acid in a cell-free system of Corynebacterium diphtheriae.
    Biochim Biophys Acta. 1973 Oct 17;326(1):52-62 PMID: 4202032
  50. Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
    Br Med J. 1973 Dec 8;4(5892):571-3 PMID: 4519012
  51. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin.
    Science. 1971 Dec 17;174(4015):1240-2 PMID: 5002466
  52. Arthritogenicity of unaltered and acetylated cell walls of mycobacteria.
    Int Arch Allergy Appl Immunol. 1969;36(3):317-20 PMID: 4982194
  53. Inhibitory effects of BCG on adenovirus tumorigenesis: dependence on administration schedule.
    Int J Cancer. 1972 Sep 15;10(2):351-6 PMID: 4661094
  54. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
    J Natl Cancer Inst. 1974 May;52(5):1643-5 PMID: 4364739
  55. Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D.
    J Immunol. 1973 Aug;111(2):599-608 PMID: 4197988
  56. BCG vaccination and leukemia mortality.
    JAMA. 1972 Dec 18;222(12):1543-4 PMID: 4678424
  57. Isolation of UDP-N-glycolylmuramyl-(Ala, Glu, DAP) from mycobacterium phlei.
    FEBS Lett. 1970 Jan 15;6(1):55-57 PMID: 11947336
  58. SULFOLIPID FROM VIRULENT TUBERCLE BACILLI.
    Proc Natl Acad Sci U S A. 1959 Dec;45(12):1801-4 PMID: 16590578
  59. Suppression of growth of Ehrlich ascites tumor cells in mice by trehalose-6,6'-dimycolate (cord factor) and BCG.
    Infect Immun. 1974 Jun;9(6):977-84 PMID: 4208531
  60. Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions.
    Immunology. 1961 Oct;4:354-65 PMID: 13918519
  61. Effects of Freund's adjuvant on adenovirus oncogenesis and antibody production in hamsters.
    Int J Cancer. 1967 Sep 15;2(5):539-43 PMID: 6081596
  62. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
    Cancer. 1973 Aug;32(2):321-7 PMID: 4722915
  63. Development of arthritis, periarthritis and periostitis in rats given adjuvants.
    Proc Soc Exp Biol Med. 1956 Jan;91(1):95-101 PMID: 13297719
  64. Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species.
    J Immunol. 1974 Jun;112(6):2028-35 PMID: 4207728
  65. [Arthrogenic activity of various mycobacterial preparations].
    C R Acad Sci Hebd Seances Acad Sci D. 1973 Nov 12;277(19):2097-100 PMID: 4208697
  66. Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.
    Int J Cancer. 1972 Sep 15;10(2):244-8 PMID: 4661092
  67. Adjuvant arthritis induced by Corynebacterium rubrum.
    Proc Soc Exp Biol Med. 1970 Jan;133(1):296-8 PMID: 5412350
  68. Chemical analysis of the mucopeptide of Mycobacterium smegmatis.
    Biochim Biophys Acta. 1969 Nov 18;192(2):358-60 PMID: 5370027
  69. Biosynthesis of corynomycolic acid from two molecules of palmitic acid.
    Nature. 1959 Nov 14;184(Suppl 20):1563-4 PMID: 13826789
  70. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
    J Natl Cancer Inst. 1973 Aug;51(2):717-20 PMID: 4765386
  71. FEBS Lett. 1970 Jan 15;6(1):37-39 PMID: 11947330
  72. [Curative treatment of Dühring-Brocq disease by BCG vaccine].
    Sem Hop. 1973 Dec 8;49(50):3357-65 contd PMID: 4366139
  73. Mycobacterial lipids: selected topics.
    Bacteriol Rev. 1972 Mar;36(1):33-64 PMID: 4553807
  74. Studies of a biochemical lesion in experimental tuberculosis in mice. X. Mitochondrial swelling induced by cord factor in vivo and accompanying biochemical change.
    Am Rev Respir Dis. 1969 Jul;100(1):42-6 PMID: 4307734
  75. [Walls of Mycobacterium tuberculosis. II. Demonstration of a mycolate of arabinobiose and a glucan in the walls of M. tuberculosis H37 Ra].
    Bull Soc Chim Biol (Paris). 1970 Mar 31;52(2):145-51 PMID: 4998136
  76. Occurrence of a galactofuranose disaccharide in immunoadjuvant fractions of Mycobacterium tuberculosis (Cell walls and wax D).
    Biochim Biophys Acta. 1973 Feb 28;297(2):423-35 PMID: 4350267
  77. [Polyunsaturated glycolipids synthesized by Mycobacterium phlei].
    Eur J Biochem. 1972 Jun 23;28(1):102-9 PMID: 5050253
  78. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    J Natl Cancer Inst. 1974 May;52(5):1571-7 PMID: 4364736
  79. Mycolic acids from "noncultivable" mycobacteria.
    Infect Immun. 1974 Jul;10(1):236-9 PMID: 4601900
  80. Adjuvant activity of monomeric bacterial cell wall peptidoglycans.
    Biochem Biophys Res Commun. 1974 Feb 4;56(3):561-7 PMID: 4597063
  81. [The chemical structure of wax D, a macromolecular peptidoglycolipid of human strains of Mycobacterium tuberculosis].
    Eur J Biochem. 1971 Jan;18(2):287-91 PMID: 5541512
  82. [ON THE CHEMICAL STRUCTURE OF MYCOSIDE B].
    Biochim Biophys Acta. 1963 Aug 27;70:442-51 PMID: 14067618
  83. Mycobacterial cell walls. II. Chemical composition of the "basal layer".
    J Bacteriol. 1963 Jan;85:24-30 PMID: 13984704
  84. Immunological effects of BCG in malignant melanoma: two modes of administration compared.
    Ann Intern Med. 1972 Mar;76(3):405-11 PMID: 5015915
  85. Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.
    Cancer Chemother Rep 3. 1973 Mar;4(2):293-8 PMID: 4729333
  86. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Nat New Biol. 1972 Aug 23;238(86):241-2 PMID: 4562114
  87. [Isolation of a new type of trehalose diester from Mycobacterium fortuitum].
    Chem Phys Lipids. 1968 Feb;2(1):11-6 PMID: 5698573
  88. Studies on cell walls of Mycobacteria. I. Chemical and biological properties of the cell walls and the mucopeptide of BCG.
    J Biochem. 1966 Apr;59(4):388-96 PMID: 4289048
  89. Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.
    Proc Natl Acad Sci U S A. 1972 Apr;69(4):855-8 PMID: 4337242
  90. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey.
    J Infect Dis. 1971 May;123(5):527-38 PMID: 5000470
  91. Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans.
    Nature. 1974 Aug 9;250(5466):517-8 PMID: 4219951
  92. INFECTIVITY, PATHOGENICITY AND SULPHOLIPID FRACTION OF SOME INDIAN AND BRITISH STRAINS OF TUBERCLE BACILLI.
    Tubercle. 1963 Dec;44:452-5 PMID: 14101326
  93. The chemical structure of the cord factor of Mycobacterium tuberculosis.
    Biochim Biophys Acta. 1956 May;20(2):299-309 PMID: 13328853
  94. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Natl Cancer Inst Monogr. 1973 Dec;39:165-75 PMID: 4595314
  95. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    J Natl Cancer Inst. 1973 May;50(5):1385-90 PMID: 4351399
  96. Immunotherapeutic and immunoprophylactic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in Swiss mice.
    J Natl Cancer Inst. 1974 Aug;53(2):459-63 PMID: 4602061
  97. CORRELATION OF ADJUVANT ACTIVITY AND CHEMICAL STRUCTURE OF WAX D FRACTIONS OF MYCOBACTERIA.
    Immunology. 1964 Mar;7:158-71 PMID: 14135432
  98. [Synthesis of cord factor analogs. II. Preparation of trehalose 6,6-dipalmitate by transesterification].
    Biochimie. 1973 May;55(5):575-8 PMID: 4201897
  99. Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.
    Nature. 1959 Jul 25;184(Suppl 5):291-2 PMID: 14428599
  100. BGG immunotherapy of local subcutaneous growths and post-surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin.
    Int J Cancer. 1973 Sep 15;12(2):420-7 PMID: 4792349
  101. Attempts to prevent acquired immunological insufficiencies in mice by bacillus Calmette-Guerin.
    Experientia. 1971 Aug;27(8):941-3 PMID: 4947883
  102. Structural study of the poly-l-Glutamic acid of the cell wall of Mycobacterium tuberculosis var hominis, strain Brevannes.
    Biochem Biophys Res Commun. 1975 Jan 20;62(2):246-52 PMID: 803372
  103. Accelerated development of transplanted mammary tumors in mice pretreated with the methanol extraction residue of BCG and prevention of acceleration by concomitant specific immunization.
    J Natl Cancer Inst. 1974 Jan;52(1):219-24 PMID: 4590011
  104. Isolation and mass spectrometric identification of the peptide subunits of mycobacterial cell walls.
    Biochem Biophys Res Commun. 1970 Jul 13;40(1):57-63 PMID: 5456965
  105. Mycolic acids of representative strains of Nocardia and the 'rhodochrous' complex.
    FEBS Lett. 1974 Mar 1;39(3):322-4 PMID: 4853302
  106. [New experimental proof of the immunizing action of methyl antigen].
    Rev Tuberc. 1953;17(10-11):1065-7 PMID: 13135252
  107. Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.
    Int J Cancer. 1974 Jul 15;14(1):137-43 PMID: 4617706
  108. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    J Natl Cancer Inst. 1972 Mar;48(3):831-5 PMID: 4333775
  109. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Cancer Res. 1974 Jul;34(7):1627-31 PMID: 4857731
  110. [N-methylation of peptides by the method of Hakomori. Structure of mycoside Cbl].
    Tetrahedron Lett. 1968 May;(26):3089-92 PMID: 5651012
  111. Granuloma formation induced in mice by chemically defined mycobacterial fractions.
    J Bacteriol. 1969 Oct;100(1):95-102 PMID: 4981067
  112. Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice.
    Cancer Res. 1973 Sep;33(9):2187-95 PMID: 4725375
  113. [Immunological properties of bacterial cell walls. Comparative study of Corynebacterium parvum and of Bacillus megaterium].
    C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 13;276(24):3233-5 PMID: 4199021
  114. Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
    Cancer Res. 1972 Jul;32(7):1584-9 PMID: 4624098
  115. Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae.
    Infect Immun. 1975 Feb;11(2):257-64 PMID: 1089598
  116. Chemical and biological basis of adjuvants.
    Mol Biol Biochem Biophys. 1973;13:1-153 PMID: 4212989
  117. Enhanced tumor growth in animals pretreated with complete Freund's adjuvant.
    J Natl Cancer Inst. 1973 Jan;50(1):209-18 PMID: 4348220
  118. Mycosides of mycobacteria.
    Am Rev Respir Dis. 1965 Dec;92(6):34-41 PMID: 5843840
  119. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties.
    Biochim Biophys Acta. 1970 Jun 9;210(1):116-26 PMID: 4989541
  120. [Trials of active immunotherapy in acute lymphocytic leukemia. Influence of different factors on results. Study of 100 cases].
    Nouv Presse Med. 1973 Mar 3;2(9):557-62 PMID: 4512967
  121. [Studies on the mycoside C 2 of the Mycobacterium avium. Structure determination].
    Eur J Biochem. 1971 Jul 29;21(2):285-91 PMID: 5563368
  122. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.
    Proc Natl Acad Sci U S A. 1972 Apr;69(4):851-4 PMID: 4502937
  123. Active immunotherapy with B.C.G. for recurrent malignant melanoma.
    Lancet. 1973 Jun 2;1(7814):1208-12 PMID: 4122562
  124. [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].
    J Reticuloendothel Soc. 1964 Jan;1:77-96 PMID: 14171321
  125. [BCG and the prevention of leukemia in animals and man].
    Bull Acad Natl Med. 1972;156:Suppl:36-43 PMID: 4576375
  126. Polyarthritis induced in the rat with cell walls from several bacteria and two Streptomyces species.
    Proc Soc Exp Biol Med. 1973 Jul;143(3):824-7 PMID: 4146337
  127. B.C.G. vaccination and leukaemia mortality.
    Lancet. 1970 Nov 7;2(7680):983-4 PMID: 4097627
  128. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Science. 1971 Apr 16;172(3980):271-3 PMID: 4323415
  129. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
    Dis Colon Rectum. 1973 Sep-Oct;16(5):341-57 PMID: 4590448
  130. [Mycolic acids. Structure, biogenesis and phylogenetic value].
    Expos Annu Biochim Med. 1967;28:77-109 PMID: 4883169
  131. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen.
    J Immunol. 1960 Oct;85:403-17 PMID: 13782608
  132. Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms.
    J Exp Med. 1950 Feb;91(2):197-218, pl PMID: 15404225
  133. Isolation and characterization of arabinose mycolate from firmly bound lipids of mycobacteria.
    J Bacteriol. 1969 Apr;98 (1):331-3 PMID: 4976469
  134. Mycosides C: behavior as receptor site substance for mycobacteriophage D4.
    J Virol. 1972 Jun;9(6):999-1003 PMID: 4113889
  135. [Chemical structure of the nitrogen part of Mycobacterium tuberculosis, var. hominis D waxes].
    C R Acad Sci Hebd Seances Acad Sci D. 1969 Dec 3;269(22):2268-70 PMID: 4983274
  136. [Characterization of mycoside variants using glycoside residues substituted with acylated chains. Mycolic nature of mycoside G'].
    Eur J Biochem. 1973 Feb 15;33(1):81-6 PMID: 4691355
  137. Effect of Bacillus Calmette-Guérin on mammary tumor formation and cellular immunity in dimethylbenz(a)anthracene-treated rats.
    Cancer Res. 1971 Aug;31(8):1061-5 PMID: 4938027
  138. The modifying effect of BCG on the immunological induction of T cells.
    J Exp Med. 1974 Jun 1;139(6):1540-52 PMID: 4598018
  139. Further study on neutralization of biochemical activity of cord factor by anti-cord factor antibody.
    Infect Immun. 1974 Jul;10(1):277-9 PMID: 4276350
  140. Antigen adjuvants.
    Mod Trends Immunol. 1967;2:28-52 PMID: 4871640
  141. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
    Science. 1974 Jul 5;185(4145):68-9 PMID: 4599426
  142. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Science. 1970 Dec 11;170(3963):1217-8 PMID: 4920656
  143. Isolation and characterization of uridine diphosphate-N-glycolylmuramyl-L-alanyl-gamma-D-glutamyl-meso-alpha,alpha'-diaminopimelic acid from Mycobacterium tuberculosis.
    Biochem Biophys Res Commun. 1970 Apr 8;39(1):7-12 PMID: 4985610
  144. Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey.
    Biochim Biophys Acta. 1970 Jun;208(3):444-51 PMID: 4990198
  145. Antibody formation to trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis.
    Infect Immun. 1972 Feb;5(2):203-12 PMID: 4117880
  146. Chemical structure and biochemical activity of cord factor analogs. 6,6'-Dimycoloyl sucrose and methyl 6-mycoloyl- -D-glucoside.
    Eur J Biochem. 1971 Oct 14;22(3):364-70 PMID: 4331058
  147. FEBS Lett. 1970 Mar 16;7(1):77-79 PMID: 11947435
  148. Isolation and biochemical activities of trehalose-6-monomycolate of Mycobacterium tuberculosis.
    Infect Immun. 1974 Jan;9(1):8-14 PMID: 4271721
  149. The mycoside capsule of Mycobacterium Avium 357.
    J Gen Microbiol. 1974 Aug;83(2):431-3 PMID: 4427104
  150. [Decrease of resistance to tumor induction by bCG vaccination].
    Vopr Onkol. 1971 Dec;17(12):87-9 PMID: 5144168
  151. The mycobacterial cell wall.
    Pure Appl Chem. 1971;25(1):135-65 PMID: 4942192
  152. [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].
    Rev Fr Etud Clin Biol. 1968 Nov;13(9):871-6 PMID: 4885127
  153. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
    Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317-25 PMID: 4606813
  154. Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria.
    Biochemistry. 1974 Aug 13;13(17):3471-6 PMID: 4210702
  155. [Antitumoral effect of peritoneal macrophages activated by a water-soluble adjuvant of mycobacterial origin].
    C R Acad Sci Hebd Seances Acad Sci D. 1974 May 27;278(22):2859-62 PMID: 4212547
  156. Radiation-killed BCG in the treatment of transplanted rat tumours.
    Int J Cancer. 1974 Jun 15;13(6):743-50 PMID: 4369104
  157. [ON BIOGENESIS OF NOCARDIC ACIDS BY NOCARDIA ASTEROIDES].
    Bull Soc Chim Biol (Paris). 1965;47:107-13 PMID: 14334803
  158. Adjuvanticity of mycobacterial cell walls.
    Jpn J Microbiol. 1971 Mar;15(2):193-7 PMID: 4930810
  159. The influence of components of M. tuberculosis and other Mycobacteria upon antibody production to ovalbumin.
    Immunology. 1958 Jan;1(1):54-66 PMID: 13513142
  160. [BIOSYNTHESIS OF C32-MYCOCEROSIC ACID; INCORPORATION OF PROPIONIC ACID].
    Biochim Biophys Acta. 1963 Dec 27;70:670-8 PMID: 14102752
  161. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.
    Infect Immun. 1974 Nov;10(5):1044-50 PMID: 16558087
  162. Chemical and immunological properties of polysaccharides of wax D extracted from Mycobacterium tuberculosis strain Aoyama B.
    J Bacteriol. 1968 Aug;96(2):567-8 PMID: 4970655
  163. A hydrosoluble, adjuvant-active mycobacterial "polysaccharide-peptidoglycan". Preparation by a simple extraction technique of the bacterial cells (strain Peurois).
    FEBS Lett. 1972 Sep 15;25(2):301-304 PMID: 11946775
  164. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids.
    Infect Immun. 1974 Jan;9(1):142-9 PMID: 4202886
  165. Structure of the cell wall of Corynebacterium diphtheriae. I. Mechanism of hydrolysis by the L-3 enzyme and the structure of the peptide.
    Biochemistry. 1968 Aug;7(8):2762-73 PMID: 5666750
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
DOI
10.1007/BF01792076
Published
1975-05-30
Pages
87-104
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
External Links
PubMed source DOI: 10.1007/BF01792076 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2